News

A new $16,000 postpartum depression drug is here. How will insurers handle it?

todayMarch 14, 2024 8

Background
share close
A much-awaited treatment for postpartum depression, zuranolone, hit the market in December, promising an accessible and fast-acting medication for a debilitating illness. But most private health insurers have yet to publish criteria for when they will cover it, according to a new analysis of insurance policies.

​ A much-awaited treatment for postpartum depression, zuranolone, hit the market in December, promising an accessible and fast-acting medication for a debilitating illness. But most private health insurers have yet to publish criteria for when they will cover it, according to a new analysis of insurance policies. Read More Breaking News, Latest News and Videos | CNN 

Written by:

Rate it